Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | CDX-527 |
Trade Name | |
Synonyms | CDX527|CDX 527 |
Drug Descriptions |
CDX-527 is a tetravalent human antibody targeting both CD27 and PD-L1 (CD274), which may lead to enhanced immune activation (AACR Annual Meeting 2019, Abstract 2392, PMID: 32451681). |
DrugClasses | CD27 Antibody 3 Immune Checkpoint Inhibitor 149 PD-L1/PD-1 antibody 122 |
CAS Registry Number | NA |
NCIT ID | C176983 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
CDX-527 | CDX-527 | 1 | 1 |